HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qinji Su Selected Research

Somatoform Disorders (Somatoform Disorder)

1/2021Frequency-specific alterations of the frontal-cerebellar circuit in first-episode, drug-naive somatization disorder.
1/2020Abnormal Functional Asymmetry in the Salience and Auditory Networks in First-episode, Drug-naive Somatization Disorder.
1/2019Increased Nucleus Accumbens Connectivity in Resting-State Patients With Drug-Naive, First-Episode Somatization Disorder.
1/2019Voxel-based global-brain functional connectivity alterations in first-episode drug-naive patients with somatization disorder.
1/2018Increased coherence-based regional homogeneity in resting-state patients with first-episode, drug-naive somatization disorder.
1/2018Bidirectional Causal Connectivity in the Cortico-Limbic-Cerebellar Circuit Related to Structural Alterations in First-Episode, Drug-Naive Somatization Disorder.
3/2016Abnormal default-mode network homogeneity and its correlations with personality in drug-naive somatization disorder at rest.
2/2016Decreased interhemispheric functional connectivity in insula and angular gyrus/supramarginal gyrus: Significant findings in first-episode, drug-naive somatization disorder.
1/2015Increased functional connectivity strength of right inferior temporal gyrus in first-episode, drug-naive somatization disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qinji Su Research Topics

Disease

9Somatoform Disorders (Somatoform Disorder)
01/2021 - 01/2015
7Schizophrenia (Dementia Praecox)
08/2021 - 03/2014
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2021

Drug/Important Bio-Agent (IBA)

15Pharmaceutical PreparationsIBA
08/2021 - 03/2014
2Olanzapine (Zyprexa)FDA Link
08/2019 - 10/2018
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2021
1Antipsychotic Agents (Antipsychotics)IBA
08/2019
1Biomarkers (Surrogate Marker)IBA
04/2014